文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

胰腺石蛋白联合qSOFA与NEWS2在急诊科早期脓毒症检测中的价值

Pancreatic Stone Protein in Co-Evaluation With QSOFA and News2 for Early Sepsis Detection at the Emergency Department.
PubMed 文献 · Shock · 2025-09-25
一句话结论在急诊疑似感染成人中,qSOFA≤1者占脓毒症82.1%,加测PSP(阈值300 ng/mL)可将特异性提至94.0%,但敏感性仅14.8%。

PROMPT研究为希腊六家医院开展的非干预性多中心试验,在急诊入院第一小时内采集362例疑似感染成人血样,回顾性用nanofluidic near-patient免疫分析设备检测PSP,并评估qSOFA与NEWS2评分。156例脓毒症中128例(82.1%)qSOFA≤1;qSOFA≥2诊断脓毒症的敏感性17.9%、特异性97.1%。在qSOFA≤1者中加测PSP(阈值300 ng/mL)后特异性94.0%、敏感性14.8%,性能接近qSOFA≥2;PSP联合NEWS2<7使真阳性病例从34例增至52例,在保持高特异性的同时提高敏感性。作者认为PSP联合现有评分系统有助于急诊高危患者早期脓毒症检测,未来将探索急诊分诊时near-patient PSP检测。

要点

  • 156例脓毒症中128例(82.1%)qSOFA≤1,单用qSOFA在急诊分诊易漏诊。
  • qSOFA≥2诊断脓毒症敏感性17.9%、特异性97.1%;qSOFA=1敏感性44.2%、特异性63.6%,qSOFA=0敏感性37.8%、特异性39.3%。
  • qSOFA≤1者加测PSP(阈值300 ng/mL)后特异性94.0%、敏感性14.8%,性能接近qSOFA≥2。
  • PSP联合NEWS2<7使真阳性病例从34例增至52例,在保持高特异性的同时提高敏感性。
  • 作者认为PSP联合现有评分系统可增强急诊高危患者早期脓毒症检测,未来将探索急诊分诊时near-patient PSP检测。

适用人群与场景

  • 急诊科入院第一小时内采集血样的成人疑似感染患者(PROMPT研究纳入362例)。

诊断标准与关键阈值

  • qSOFA评分≥2、=1、=0分别用于诊断脓毒症;PSP阈值300 ng/mL;NEWS2 cutoff≥7与<7。

研究设计与关键结果

  • PROMPT研究为非干预性多中心试验,覆盖希腊六家医院,纳入362例急诊疑似感染成人,入院第一小时内采血,回顾性用nanofluidic near-patient免疫分析设备(abioSCOPE,Abionic SA,Switzerland)检测PSP并评估qSOFA与NEWS2。
  • 156例脓毒症中128例(82.1%)qSOFA≤1。
  • qSOFA≥2诊断脓毒症敏感性17.9%、特异性97.1%;qSOFA=1敏感性44.2%、特异性63.6%;qSOFA=0敏感性37.8%、特异性39.3%。
  • qSOFA≤1者加测PSP(阈值300 ng/mL)后特异性94.0%、敏感性14.8%,性能接近qSOFA≥2。
  • PSP联合NEWS2<7使真阳性病例从34例增至52例,在保持高特异性的同时提高敏感性。

证据类型、等级与局限

  • 证据类型:非干预性多中心试验(PROMPT研究),回顾性PSP检测分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,将PSP与现有评分系统(qSOFA或NEWS2)联合可增强急诊高危患者的早期脓毒症检测。
  • 未来研究将探索急诊分诊时near-patient PSP检测,以进一步优化和加速脓毒症管理。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early sepsis identification at the emergency department (ED) triage is essential for timely treatment and improved outcomes. This study evaluated the diagnostic performance of pancreatic stone protein (PSP) in combination with the quick Sequential Organ Failure Assessment (qSOFA) and the National Early Warning Score (NEWS2) for early sepsis detection.

METHODS: As part of the PROMPT study-a noninterventional, multicenter trial across six Greek hospitals-blood samples were collected within the first hour of admission in the emergency department. PSP levels were retrospectively assessed using a nanofluidic near-patient immunoassay device (abioSCOPE, Abionic SA, Switzerland) in 362 adult patients with suspected infections and evaluated their qSOFA and NEWS2 scores. Objectives included evaluating qSOFA's performance, assessing the performance of PSP to identify high-risk patients with qSOFA ≤1, and determining the added value of combining PSP with qSOFA or NEWS2 (cutoff ≥7), using standard performance metrics.

RESULTS: Among 156 sepsis cases, 128 (82.1%) had qSOFA scores ≤1. A qSOFA score ≥2 demonstrated sensitivity 17.9% and specificity 97.1% for sepsis diagnosis. In comparison, a qSOFA score of 1 showed a sensitivity of 44.2% and a specificity of 63.6%, while a score of 0 yielded a sensitivity of 37.8% and a specificity of 39.3%. The addition of PSP (cutoff: 300 ng/mL) to qSOFA ≤1 improved specificity to 94.0%, with a sensitivity of 14.8%-closely mirroring the performance of qSOFA ≥2. Similarly, combining PSP with NEWS2 <7 increased true positive cases from 34 to 52, enhancing sensitivity while maintaining high specificity.

CONCLUSIONS: This study highlights the utility of combining PSP levels in the patient's blood with existing scoring systems to enhance early sepsis detection in high-risk ED patients. Future research will explore near-patient PSP measurements at ED triage to further refine and expedite sepsis management.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Safarika A, Damoraki G, Katsaros K, et al. Pancreatic Stone Protein in Co-Evaluation With QSOFA and News2 for Early Sepsis Detection at the Emergency Department. Shock. 2025. PMID: 40997264. doi:10.1097/SHK.0000000000002720

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。